MentionFox
Home › Layoffs › Lyell Immunopharma, Inc.
SEC filings · Form 8-K, Item 2.05

Lyell Immunopharma, Inc. layoffs and restructuring

Before you join, sell to or invest in Lyell Immunopharma, Inc.

MentionFox check on Lyell Immunopharma, Inc.: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/lyell-immunopharma

  • Note: Layoff plan disclosed Apr 2025 (about 73 employees) (filing)

New since last check: Layoff plan disclosed Apr 2025 (about 73 employees) (filing, first seen 14 November 2026).

Check Lyell Immunopharma, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Lyell Immunopharma, Inc.?

Every exit or restructuring plan Lyell Immunopharma, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 73 employees are affected, according to Lyell Immunopharma, Inc.'s latest layoff filing, on April 1, 2025. As of November 15, 2026, Lyell Immunopharma, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, April 1, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Gates Frontier, LLC also filed stake reports on 1 other company ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Lyell Immunopharma, Inc.

Free to see. No signup.

People from Lyell Immunopharma, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Lyell Immunopharma, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees73
Latest filing2025-04-01

Lyell Immunopharma, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Lyell Immunopharma have layoffs in 2025? What its filings say

Lyell Immunopharma, Inc. (CIK 1806952) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-04-01

Employees affected

The Board also approved the reduction of the Company's workforce in West Hills by approximately 73 employees related to such closure.

Locations

As a result, on March 31, 2025, Lyell's Board of Directors (the "Board") approved the closure of the West Hills manufacturing facility acquired as part of Lyell's acquisition of ImmPACT Bio in 2024.

Expected charges

In connection with these actions, the Company expects to incur aggregate expenses of between $3.0 million to $4.0 million, related to severance, benefits, payroll taxes, and other workforce reduction costs, which are expected to be recognized primarily in the second and third quarters of 2025.

Also on the record for Lyell Immunopharma, Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G/A, by ARCH Venture Fund IX, L.P.17.4% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by James B. Tananbaum2.7% of the class5%+ stakesSource
June 18, 2026Stake report, Schedule 13G/A, by Innovative Cellular Therapeutics Holdings Limited12.3% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by ARCH Venture Fund IX, L.P.13.9% of the class5%+ stakesSource
May 11, 2026Stake report, Schedule 13G/A, by MWG Caph Ltd4.3% of the class5%+ stakesSource
May 8, 2026Stake report, Schedule 13G/A, by Explore Investments LLC6.6% of the class5%+ stakesSource
April 21, 2026Stake report, Schedule 13G, by EULER FUND, L.P.6.71% of the class5%+ stakesSource
March 9, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
November 14, 2025Stake report, Schedule 13G/A, by ARCH Venture Fund IX, L.P.13% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by James B. Tananbaum7.6% of the class5%+ stakesSource
November 13, 2025Stake report, Schedule 13G, by Innovative Cellular Therapeutics Holdings Ltd9.8% of the class5%+ stakesSource
November 12, 2025Stake report, Schedule 13G/A, by Newton (PTC) Limited3.93% of the class5%+ stakesSource

Keep reading

More on Lyell Immunopharma, Inc. and the records around it.

Lyell Immunopharma, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Lyell Immunopharma, Inc.?

Want the whole picture on Lyell Immunopharma, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Lyell Immunopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Lyell Immunopharma, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 14 records.

Tools for this story

Each opens in a new tab, filled in for Lyell Immunopharma, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/lyell-immunopharma
Last updated 2026-11-15
Lyell Immunopharma, Inc. layoffs 2025: about 73 jobs (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/lyell-immunopharma